Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab plus topical calcipotriol/betamethasone versus vehicle topical treatment in moderate to severe plaque psoriasis
NL-OMON30874Phase 3Active, not recruiting
- Sponsor
- Abbott Laboratories
- Start
- Jan 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in plaque psoriasis and psoriasis comparing Adalimumab + calcipotriol/betamethasone with Adalimumab + vehicle ointment (2 arms). Primary endpoints: PASI 75 at week 16 and Safety. Started Jan 2008; status: active, not recruiting.
02
Drugs
adalimumabcalcipotriol + betamethasone
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on NL-OMON30874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30874.